Meru Biotechnologies
Richmond, US · Founded 2019 · Virginia corporation
Founders & leadership
DR
Daniel RodenhaverManager and Chief Executive Officer
TS
Theresa SchaubManager and Chief Commercialization Officer
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 2 rounds · 2019–2020
▶$200KraisedMar 2021 · 1 investors · BiotechnologyRule 506(c)
▶$200KraisedMar 2021 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Daniel RodenhaverExecutive Officer, Director
- Theresa SchaubExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $200K
- Sales commissions
- $52K
- Placement agents
- First Liberties Securities, Inc. (dba First Liberties Financial)
- First sale
- Oct 2020
- Incorporated
- Corporation, Virginia, 2019
- Federal exemptions
- 06c
▶$1MraisedAug 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedAug 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel RodenhaverExecutive Officer, Director
- Theresa SchaubExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1M
- Proceeds to insiders
- $240K
- First sale
- Aug 2019
- Incorporated
- Limited Liability Company, Virginia, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Meru Biotechnologies raised?
- Meru Biotechnologies has disclosed $1.2M raised across 2 rounds.
- Where is Meru Biotechnologies headquartered?
- Meru Biotechnologies is headquartered in Richmond, US.